Hernandez-Ilizaliturri, F. J.: шукати на сайті Z-Library

Runckel, Kyle, Barth, Matthew J., Mavis, Cory, Gu, Juan J., Hernandez-Ilizaliturri, Francisco J.

Рік:

2017

Мова:

english

Файл:

PDF, 418 KB

english, 2017

The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma

Журнал:

Blood Advances

Рік:

2018

Файл:

PDF, 1.28 MB

2018

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study

Jorge J. Castillo, Brady E. Beltran, Michele Bibas, Mark Bower, Jaime A. Collins, Kate Cwynarski, Jose L. Diez-Martin, Francisco Hernandez-Ilizaliturri, Steven M. Horwitz, Silvia Montoto, Liron Pantan

Журнал:

American Journal of Hematology

Рік:

2011

Мова:

english

Файл:

PDF, 233 KB

english, 2011

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell–like than in germinal center B-cell–like phenotype

Francisco J. Hernandez-Ilizaliturri, George Deeb, Pier L. Zinzani, Stefano A. Pileri, Farhana Malik, William R. Macon, Andre Goy, Thomas E. Witzig, Myron S. Czuczman

Журнал:

Cancer

Рік:

2011

Мова:

english

Файл:

PDF, 477 KB

english, 2011

Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature

Gayatri Vaidyanathan, Nuttapong Ngamphaiboon, Francisco J. Hernandez-Ilizaliturri

Журнал:

Annals of Hematology

Рік:

2011

Мова:

english

Файл:

PDF, 147 KB

english, 2011

Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms

Wasif Riaz, Francisco J. Hernandez-Ilizaliturri, Myron S. Czuczman

Журнал:

Immunologic Research

Рік:

2010

Мова:

english

Файл:

PDF, 337 KB

english, 2010

Pro-apoptotic therapy with the oligonucleotide GenasenseTM (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab

Jeyanthi Ramanarayanan, Francisco J. Hernandez-Ilizaliturri, Asher Chanan-Khan, Myron S. Czuczman

Журнал:

Рік:

2004

Мова:

english

Файл:

PDF, 297 KB

english, 2004

Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo

Nishitha Reddy, Francisco J. Hernandez-Ilizaliturri, George Deeb, Mark Roth, Mary Vaughn, Joy Knight, Paul Wallace, Myron S. Czuczman

Журнал:

Рік:

2008

Мова:

english

Файл:

PDF, 492 KB

english, 2008

A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients

Taimur Sher, Sikander Ailawadhi, Kena C. Miller, Debbie Manfredi, Margaret Wood, Wei Tan, Gregory Wilding, Myron S. Czuczman, Francisco J. Hernandez-Ilizaliturri, Fredrick Hong, Raman Sood, Saif Soniw

Журнал:

Matthew J. Barth, Francisco J. Hernandez-Ilizaliturri, Cory Mavis, Ping-Chiao Tsai, John F. Gibbs, George Deeb, Myron S. Czuczman

Рік:

2011

Мова:

english

Файл:

PDF, 130 KB

english, 2011

Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma

Журнал:

Bone Marrow Transplantation

Рік:

2012

Мова:

english

Файл:

PDF, 338 KB

english, 2012

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

Benekli, M, Smiley, S L, Younis, T, Czuczman, M S, Hernandez-Ilizaliturri, F, Bambach, B, Battiwalla, M, Padmanabhan, S, McCarthy, P L, Hahn, T

Журнал:

Рік:

2007

Мова:

english

Файл:

PDF, 175 KB

english, 2007

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

Wierda, W. G., Kipps, T. J., Durig, J., Griskevicius, L., Stilgenbauer, S., Mayer, J., Smolej, L., Hess, G., Griniute, R., Hernandez-Ilizaliturri, F. J., Padmanabhan, S., Gorczyca, M., Chang, C.-N., C

Журнал:

Blood

Рік:

2011

Мова:

english

Файл:

PDF, 413 KB

english, 2011

Primary Esophageal Lymphoma: Case Series and Review of the Literature

Krishdeep Singh Chadha, Francisco J. Hernandez-Ilizaliturri, Milind Javle

Журнал:

Digestive Diseases and Sciences

Рік:

2006

Мова:

english

Файл:

PDF, 749 KB

english, 2006

The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL)

Richa Dawar, Francisco Hernandez-Ilizaliturri

Журнал:

Best Practice & Research Clinical Haematology

Рік:

2012

Мова:

english

Файл:

PDF, 248 KB

english, 2012

The Use of Galiximab in Non-Hodgkin Lymphoma

Vinjamaram, Sanjay, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Журнал:

Clinical Lymphoma & Myeloma

Рік:

2008

Мова:

english

Файл:

PDF, 230 KB

english, 2008

Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial

William G. Wierda, Thomas J. Kipps, Jan Dürig, Laimonas Griskevicius, Stephan Stilgenbauer, Jiri Mayer, Lukas Smolej, Georg Hess, Rasa Griniute, Francisco J. Hernandez-Ilizaliturri, Swaminathan Padman

Журнал:

Clinical Lymphoma Myeloma and Leukemia

Рік:

2010

Мова:

english

Файл:

PDF, 70 KB

english, 2010

CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma

Cruz, Raymond I., Hernandez-Ilizaliturri, Francisco J., Olejniczak, Scott, Deeb, George, Knight, Joy, Wallace, Paul, Thurberg, Beth L., Kennedy, William, Czuczman, Myron S.

Журнал:

Kun, Lillian, Hernandez-Ilizaliturri, Francisco J., Reddy, Nishitha M.

Рік:

2007

Мова:

english

Файл:

PDF, 1.61 MB

english, 2007

Novel Therapeutic Strategies for Cutaneous T-Cell Lymphoma in Advanced Stages

Журнал:

Seminars in Hematology

Рік:

2014

Мова:

english

Файл:

PDF, 181 KB

english, 2014

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics

Sher, Taimur, Miller, Kena C., Lawrence, David, Whitworth, Amy, Hernandez-Ilizaliturri, Francisco, Czuczman, Myron S., Miller, Austin, Lawrence, William, Bilgrami, Syed Ali, Sood, Raman, Wood, Margare

Журнал:

Hernandez-Ilizaliturri, Francisco J., Jupudy, Venkata, Reising, Scott, Repasky, Elizabeth A., Czuczman, Myron S.

Рік:

2010

Мова:

english

Файл:

PDF, 192 KB

english, 2010

Concurrent administration of granulocyte colony-stimulating factoror granulocyte-monocyte colony-stimulating factor enhancesthe biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model

Журнал:

Klanova, Magdalena, Soukup, Tomas, Jaksa, Radek, Molinsky, Jan, Lateckova, Lucie, Maswabi, Bokang CL, Prukova, Dana, Brezinova, Jana, Michalova, Kyra, Vockova, Petra, Hernandez-Ilizaliturri, Francisco

Рік:

2005

Мова:

english

Файл:

PDF, 358 KB

english, 2005

Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research

Журнал:

Laboratory Investigation

Рік:

2014

Мова:

english

Файл:

PDF, 685 KB

english, 2014

Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis

Evens, A. M., Advani, R., Press, O. W., Lossos, I. S., Vose, J. M., Hernandez-Ilizaliturri, F. J., Robinson, B. K., Otis, S., Nadav Dagan, L., Abdallah, R., Kroll-Desrosiers, A., Yarber, J. L., Sandov

Журнал:

Journal of Clinical Oncology

Рік:

2013

Мова:

english

Файл:

PDF, 121 KB

english, 2013

MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma

Wenzel, S-S, Grau, M, Mavis, C, Hailfinger, S, Wolf, A, Madle, H, Deeb, G, Dörken, B, Thome, M, Lenz, P, Dirnhofer, S, Hernandez-Ilizaliturri, F J, Tzankov, A, Lenz, G

Журнал:

Leukemia

Рік:

2013

Мова:

english

Файл:

PDF, 1.49 MB

english, 2013

Novel disease targets and management approaches for diffuse large B-cell lymphoma

Wilson, Wyndham H., Hernandez-Ilizaliturri, Francisco J., Dunleavy, Kieron, Little, Richard F., O'Connor, Owen A.

Журнал:

Tsai, P.-C., Hernandez-Ilizaliturri, F. J., Bangia, N., Olejniczak, S. H., Czuczman, M. S.

Рік:

2010

Мова:

english

Файл:

PDF, 242 KB

english, 2010

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma

Журнал:

Рік:

2012

Мова:

english

Файл:

PDF, 1.99 MB

english, 2012

Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels

Czuczman, M. S., Olejniczak, S., Gowda, A., Kotowski, A., Binder, A., Kaur, H., Knight, J., Starostik, P., Deans, J., Hernandez-Ilizaliturri, F. J.

Журнал:

Castillo, Jorge J, Chavez, Julio C, Hernandez-Ilizaliturri, Francisco J, Montes-Moreno, Santiago

Рік:

2008

Мова:

english

Файл:

PDF, 584 KB

english, 2008

Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma

Straus, D. J., Duvic, M., Horwitz, S. M., Hymes, K., Goy, A., Hernandez-Ilizaliturri, F. J., Feldman, T., Wegner, B., Myskowski, P. L.

Журнал:

Annals of Oncology

Рік:

2014

Мова:

english

Файл:

PDF, 343 KB

english, 2014

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

Журнал:

Expert Review of Hematology

Рік:

2015

Мова:

english

Файл:

PDF, 1.05 MB

english, 2015

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma

Witzig, T. E., Nowakowski, G. S., Habermann, T. M., Goy, A., Hernandez-Ilizaliturri, F. J., Chiappella, A., Vitolo, U., Fowler, N., Czuczman, M. S.

Журнал:

Annals of Oncology

Рік:

2015

Мова:

english

Файл:

PDF, 187 KB

english, 2015

Vascular Endothelial Growth Factor Polymorphisms in Early-Stage Non-Small-Cell Lung Cancer

Patel, M., Ailawadhi, S., Hernandez-Ilizaliturri, F., Wilding, G. E.

Журнал:

Journal of Clinical Oncology

Рік:

2008

Мова:

english

Файл:

PDF, 50 KB

english, 2008

Diffuse Large B-Cell Lymphoma Presenting As Pancoast Tumor

Ngamphaiboon, N., Pukiat, S., Kandimalla, Y., Hernandez-Ilizaliturri, F. J., Rooney, J. J.

Журнал:

Journal of Clinical Oncology

Рік:

2010

Мова:

english

Файл:

PDF, 1.55 MB

english, 2010

MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models

Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Mavis, Cory, Czuczman, Natalie M., Deeb, George, Gibbs, John, Skitzki, Joseph J., Patil, Ritesh, Czuczman, Myron S.

Журнал:

Anti-Cancer Drugs

Рік:

2013

Мова:

english

Файл:

PDF, 643 KB

english, 2013

Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model

Hernandez-Ilizaliturri, F. J.

Журнал:

Maddipatla, S., Hernandez-Ilizaliturri, F. J., Knight, J., Czuczman, M. S.

Рік:

2005

Мова:

english

Файл:

PDF, 704 KB

english, 2005

Augmented Antitumor Activity against B-Cell Lymphoma by a Combination of Monoclonal Antibodies Targeting TRAIL-R1 and CD20

Журнал:

Olejniczak, S. H., Hernandez-Ilizaliturri, F. J., Clements, J. L., Czuczman, M. S.

Рік:

2007

Мова:

english

Файл:

PDF, 524 KB

english, 2007

Acquired Resistance to Rituximab Is Associated with Chemotherapy Resistance Resulting from Decreased Bax and Bak Expression

Журнал:

Рік:

2008

Мова:

english

Файл:

PDF, 871 KB

english, 2008

Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents

Frys, Sarah, Simons, Zachary, Hu, Qiang, Barth, Matthew J., Gu, Juan J., Mavis, Cory, Skitzki, Joseph, Song, Liu, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Журнал:

Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Kaufman, Gregory P., Czuczman, Natalie M., Mavis, Cory, Skitzki, Joseph J., Czuczman, Myron S.

Рік:

2015

Мова:

english

Файл:

PDF, 1.64 MB

english, 2015

The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma

Журнал:

Batoo, S. A., Hernandez-Ilizaliturri, F.

Рік:

2013

Мова:

english

Файл:

PDF, 445 KB

english, 2013

The emerging role of lenalidomide in the management of lymphoid malignancies

Журнал:

Therapeutic Advances in Hematology

Рік:

2011

Мова:

english

Файл:

PDF, 131 KB

english, 2011

Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma

Barth, M. J., Mavis, C., Czuczman, M. S., Hernandez-Ilizaliturri, F. J.

Журнал:

Journal of Cancer Research and Clinical Oncology

Рік:

2015

Мова:

english

Файл:

PDF, 6.81 MB

english, 2015

Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents

K. Xue, J. J. Gu, Q. Zhang, C. Mavis, F. J. Hernandez-ilizaliturri, M. S. Czuczman, Y. Guo

Журнал:

Рік:

2016

Мова:

english

Файл:

PDF, 1.14 MB

english, 2016

Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies

Lasorsa, E, Smonksey, M, Kirk, J S, Rosario, S, Hernandez-Ilizaliturri, F J, Ellis, L

Журнал:

Cell Death and Disease

Рік:

2015

Мова:

english

Файл:

PDF, 1.49 MB

english, 2015

Immune Reconstitution after Autologous Hematopoietic Cell Transplant (AHCT) in B-Cell Non-Hodgkin Lymphoma (B-NHL) Patients Mobilized with Granulocyte Colony Stimulating Factor (G-CSF), with or without Plerixafor

Torka, Pallawi, Wallace, Paul K., Zhang, Yali, Chen, George L., Ho, Christine M., Balderman, Sophia R., Ross, Maureen, Paiva, Bruno, Hernandez-Ilizaliturri, Francisco J., McCarthy, Philip L., Hahn, Th

Журнал:

Biology of Blood and Marrow Transplantation

Рік:

2016

Мова:

english

Файл:

PDF, 199 KB

english, 2016

Peg-filgrastim potentiates rituximab in patients with indolent lymphomas: results of a phase II study

Torka, Pallawi, Patel, Priyank, Tan, Wei, Wilding, Gregory, Mavis, Cory, Deeb, George, Lee, Kelvin, Bhat, Seema, Czuczman, Myron, Hernandez-Ilizaliturri, Francisco J.

Журнал:

Clinical Lymphoma Myeloma and Leukemia

Рік:

2015

Мова:

english

Файл:

PDF, 61 KB

english, 2015

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort

Evens, Andrew M., Kanakry, Jennifer A., Sehn, Laurie H., Kritharis, Athena, Feldman, Tatyana, Kroll, Aimee, Gascoyne, Randy D., Abramson, Jeremy S., Petrich, Adam M., Hernandez-Ilizaliturri, Francisco

Журнал:

American Journal of Hematology

Рік:

2015

Мова:

english

Файл:

PDF, 569 KB

english, 2015

Multimodality Therapy for Thymic Carcinoma (TCA)

Hernandez-Ilizaliturri, Francisco J., Tan, Dongfeng, Cipolla, David, Connolly, Gregory, Debb, George, Ramnath, Nithya

Журнал:

American Journal of Clinical Oncology

Рік:

2004

Мова:

english

Файл:

PDF, 496 KB

english, 2004

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy

Jewell, Roxanne C., Kipps, Thomas J., Dürig, Jan, Griskevicius, Laimonas, Stilgenbauer, Stephan, Smolej, Lukáš, Mayer, Jiří, Hess, Georg, Hernandez-Ilizaliturri, Francisco J., Padmanabhan-Iyer, Swamin

Журнал: